Xenon Pharmaceuticals Inc.
XENE | NASDAQ
$38.72
-$0.27 (-0.69%)
Sep 22, 2026, 1:20 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 199.16M | 142.71M | 148.64M | 57.24M | 175.69M | 45.01M |
Short-Term Investments | 349.72M | 484.19M | 489.44M | 534.85M | 376.09M | 131.99M |
Long-Term Investments | 37.15M | 127.5M | 292.79M | 128.68M | n/a | n/a |
Other Long-Term Assets | 7.15M | 7.5M | 7.4M | 7.75M | n/a | n/a |
Receivables | 1.37M | 1.47M | 874K | 986K | 2.77M | 1.82M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 10.39M | 6.89M | 6.01M | 7.23M | n/a | n/a |
Total Current Assets | 560.65M | 635.26M | 644.96M | 600.3M | 559.02M | 181.78M |
Property-Plant & Equipment | 15.35M | 18.22M | 18.85M | 16.91M | 12.52M | 6.88M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 421.02M | 162.88M | 319.84M | 153.85M | 12.99M | 7.4M |
Total Assets | 981.67M | 798.14M | 964.8M | 754.15M | 572.01M | 189.19M |
Account Payables | 3.89M | 5.07M | 8.6M | 8.49M | 3.82M | 3.04M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 3.64M |
Short-Term Debt | 1.53M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 21.6M | 9.93M | 347K | 5.82M | 5.94M | 2.86M |
Total Current Liabilities | 41.79M | 35.59M | 27.27M | 22.7M | 14.32M | 14.78M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 3.2M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 358.12M | 7.65M | 9.6M | 9.95M | 7.65M | 3.05M |
Total Liabilities | 399.91M | 43.24M | 36.88M | 32.65M | 21.97M | 17.83M |
Total Debt | 7.94M | 9.02M | 10.9M | 10.44M | 8.26M | 3.32M |
Book Value | 581.76M | 754.9M | 927.92M | 721.5M | 550.03M | 171.36M |
Book Value Per Share | 7.34 | 9.69 | 13.87 | 11.92 | 12.61 | 4.96 |
Common Stock | 1.6B | 1.46B | 1.44B | 1.07B | 783.17M | 397.75M |
Retained Earnings | -1.25B | -899.47M | -665.14M | -482.75M | -357.37M | -278.49M |
Comprehensive Income | 335K | -1.61M | -77K | -3M | -990K | -990K |
Shareholders Equity | 581.76M | 754.9M | 927.92M | 721.5M | 550.03M | 171.36M |
Total Investments | 386.88M | 611.69M | 782.23M | 663.53M | 376.09M | 131.99M |
Add to Watchlist
Select watchlists to add or remove XENE